European Finance News

MOLOGEN AG: Expanded Manufacturing Authorisation For MIDGE®-based active Substances

🕔1/19/2009 6:07:00 PM

Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Lesen Sie die komplette Artikel

Rautaruukki Oyj (HEL:RTRKS) Preliminary Information On 2008 Results: Rautaruukki's Comparable Operating Profit Below That For Previous Year

🕔1/19/2009 6:03:01 PM

Rautaruukki Oyj (HEL:RTRKS) Rautaruukki Corporation Stock exchange release 19 January 2009 at 9am

Lesen Sie die komplette Artikel

Copeinca (OSL:COP) COPEINCA ASA FINANCIAL CALENDAR 2009

🕔1/19/2009 6:03:00 PM

Copeinca (OSL:COP) 26.02.2009 Results 2008 / Q4 2008

Lesen Sie die komplette Artikel

Elisa Oyj (HEL:ELI1V) Elisa Extends Its Corporate Customer Service In Russia

🕔1/19/2009 6:03:00 PM

Elisa Oyj (HEL:ELI1V) Press release, 19 January 2009

Lesen Sie die komplette Artikel

SEB (STO:SEBA) Rated Best Overall Bank For Cash Management 2009 In The Nordic Region

🕔1/19/2009 6:01:00 PM

SEB (STO:SEBA) SEB has been named Best Overall Bank for Cash Management 2009 in the Nordic Region, as well as Best bank for Liquidity Management, and Best bank for Risk Management 2009 in the Nordic Region in Global Finance's survey on the World's Best Treasury and Cash management Providers 2009 to be published in March.

Lesen Sie die komplette Artikel

Akzo Nobel NV (AMS:AKZA) AkzoNobel Finalizes Acquisition Of LII Europe Activities

🕔1/19/2009 6:01:00 PM

Akzo Nobel NV (AMS:AKZA) AkzoNobel has completed the acquisition of the business and assets of the German-based company LII Europe. The acquired activities will be integrated into AkzoNobel Industrial Chemicals. Financial details were not disclosed.

Lesen Sie die komplette Artikel

Galapagos NV (EBR:GLPG) Galapagos And GlaxoSmithKline Expand Anti-infectives Alliance

🕔1/19/2009 5:33:00 PM

Galapagos NV (EBR:GLPG) Mechelen, Belgium; 19 January 2009 - Galapagos NV (Euronext: GLPG) announced today that it has expanded the alliance in antibacterials and antivirals with GlaxoSmithKline (GSK) to include three more discovery targets. For this expansion, Galapagos receives a payment from GSK of €2 million cash.

Lesen Sie die komplette Artikel